5 quarters tracked · Beat rate 0% · Updated quarterly
| Period | Report Date | EPS Estimate | EPS Actual | Surprise | Result |
|---|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $7.83 | $7.78 | -0.6% | Miss |
| Q1 2026 | 2026-03-31 | $7.84 | $7.79 | -0.7% | Miss |
| Q4 2025 | 2025-12-31 | $8.11 | $8.08 | -0.4% | Miss |
| Q3 2025 | 2025-09-30 | $7.88 | $7.83 | -0.6% | Miss |
| Q2 2025 | 2025-06-30 | $7.37 | $7.20 | -2.3% | Miss |
Earnings Beat Rate
Cigna has beaten analyst EPS estimates in 0 of 5 tracked quarters (0% beat rate). Data sourced from SEC filings and analyst consensus. View full AI analysis →